Areas of activity:
Areas of activity: neurology, endocrinology, ophthalmology. It has representative offices in 77 constituent entities of the Russian Federation and 5 countries worldwide.
It implements projects under the Federal Target Programs of the Ministry of Industry and Trade of the Russian Federation and the Ministry of Education and Science of the Russian Federation. As part of the Pharma-2020 program, Geropharm launched Russia's only industrial full-cycle production of genetically engineered insulin, from substance synthesis to finished dosage form, in Obolensk (Moscow Region). Since 2021, the same plant has launched production of the EpiVacCorona coronavirus vaccine.
Geropharm divisions:
- Full-cycle development and production of medicinal products for the treatment of socially significant diseases.
- Investment in technological development and the creation of modern pharmaceutical infrastructure.
- Implementation of import substitution tasks within the framework of federal government programs.
- Leadership in diabetology.
- Development of active pharmaceutical ingredient production.
Areas of activity: neurology, endocrinology, ophthalmology. It has representative offices in 77 constituent entities of the Russian Federation and 5 countries worldwide.
It implements projects under the Federal Target Programs of the Ministry of Industry and Trade of the Russian Federation and the Ministry of Education and Science of the Russian Federation. As part of the Pharma-2020 program, Geropharm launched Russia's only industrial full-cycle production of genetically engineered insulin, from substance synthesis to finished dosage form, in Obolensk (Moscow Region). Since 2021, the same plant has launched production of the EpiVacCorona coronavirus vaccine.
Geropharm divisions:
- Geropharm LLC — parent company — production and distribution of pharmaceuticals;
- Geropharm-Bio OJSC (formerly National Biotechnologies) is a modern full-cycle biotechnological GMP production facility;
- Pharm-Holding CJSC is an R&D division: full cycle of drug development from molecule to registration[10]. Located in the Neudorf Special Economic Zone.
Website: https://geropharm.ru/
Office Address: 197046, St. Petersburg, Chapaeva St. 15, bldg. 2B, Senator Business Center, 9th floor
Phone: +7 (812) 703-79-75
E-mail: inform@geropharm.ru
R&D Center Address: 198515, St. Petersburg, Strelna, Svyazi St., 34-A
Phone: +7 (812) 493-55-01
E-mail: inform@pharmholding.com
Office Address: 197046, St. Petersburg, Chapaeva St. 15, bldg. 2B, Senator Business Center, 9th floor
Phone: +7 (812) 703-79-75
E-mail: inform@geropharm.ru
R&D Center Address: 198515, St. Petersburg, Strelna, Svyazi St., 34-A
Phone: +7 (812) 493-55-01
E-mail: inform@pharmholding.com
Similar technology companies
